Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Non-Current Deferred Tax Liability (2016 - 2026)

Standard Biotools has reported Non-Current Deferred Tax Liability over the past 12 years, most recently at $810000.0 for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 94.43% to $810000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $810000.0 through Dec 2025, down 94.43% year-over-year, with the annual reading at $810000.0 for FY2025, 94.43% down from the prior year.
  • Non-Current Deferred Tax Liability was $810000.0 for Q4 2025 at Standard Biotools, down from $1.1 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $14.5 million in Q4 2024 and troughed at $620000.0 in Q3 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $1.1 million (2022), against an average of $2.8 million.
  • Year-over-year, Non-Current Deferred Tax Liability soared 1629.01% in 2024 and then plummeted 94.43% in 2025.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $4.3 million in 2021, then tumbled by 75.63% to $1.1 million in 2022, then fell by 20.28% to $841000.0 in 2023, then soared by 1629.01% to $14.5 million in 2024, then plummeted by 94.43% to $810000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Non-Current Deferred Tax Liability are $810000.0 (Q4 2025), $1.1 million (Q3 2025), and $1.1 million (Q2 2025).